Tulip joins Neoprobe as exec VP, business chief
Thomas Tulip, PhD, has joined radiopharmaceutical developer Neoprobe as executive vice president and chief business officer.

Prior to joining Neoprobe, Tulip held senior leadership positions at Alseres Pharmaceuticals, Lantheus Medical Imaging, Bristol Myers Squibb (BMS) and DuPont, where his roles spanned product discovery and development, business and technology planning, brand and alliance management and international business management.

Most recently, as president of Alseres Molecular Imaging, Tulip led efforts to develop markets for a Phase III neuroimaging agent. While at DuPont and BMS, he helped develop, commercialize and manage the nuclear cardiology franchise.